News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Lebrikizumab relieves itch, skin pain in AD patients previously on dupilumab
28 Mar 2025
byStephen Padilla
The use of lebrikizumab improves the symptoms of moderate-to-severe atopic dermatitis (AD) in patients previously treated with dupilumab, reports a study presented at AAD 2025.








